Search Results
May 12, 2026, 09:00 ET Circet Announces Evolution of U.S. Executive Leadership and Appointment of Bill Hogg as CEO of Circet USA
Chief Executive Officer of Gigapower LLC, an AT&T and BlackRock joint venture, where he built one of the largest open‑access fiber‑to‑the‑home platforms in the United States from the ground up. Prior to Gigapower, he held senior leadership roles at AT&T Inc. spanning global technology operations,
More news about: Circet USA
May 12, 2026, 08:42 ET Zackat Labs, AT&T Business and RCW Energy Services Unveil Innovative Connected Safety Platform with Wearable Heat Stress and Gas Monitoring Solution
solutions.About AT&T Business: AT&T Business offers a wide range of solutions designed to meet the needs of companies of all sizes. Our services include high-speed internet, robust networking, mobile connectivity, cybersecurity, cloud services, and IoT solutions. AT&T Business also provides
More news about: Zackat Labs, Inc.
May 12, 2026, 08:30 ET T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR APRIL 2026
BALTIMORE, May 12, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced April month-end assets under management of $1.83 trillion. Net outflows for April 2026 were $10.6 billion driven by a few large redemptions
More news about: T. Rowe Price Group
May 12, 2026, 08:30 ET Bubble Skincare and American Eagle Come Together to Celebrate the Power of Community, Comfort and Everyday Rituals
including but not limited to:EXCLUSIVE AE x Bubble Boxy Graphic T-Shirt (Mint), $34.95EXCLUSIVE AE x Bubble Fleece Hoodie (Lavender), $64.95AE x Bubble Boxy Graphic T-Shirt, $34.95AE x Bubble Fleece Hoodie (available in Chalk, Blooming Bright Blue &
More news about: Bubble Beauty Inc.
May 12, 2026, 08:03 ET Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
NextCure, Inc., overseeing first-in-human and proof-of-concept oncology trials, and Chief Medical Officer of NexImmune, Inc., a clinical-stage developer of T cell–based immunotherapies.Earlier in his industry career, Dr. Myint held senior leadership roles at Celgene Corporation (now part of Bristol Myers
More news about: Halia Therapeutics
May 12, 2026, 07:30 ET TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
drug conjugates (ADCs) targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies.For more information, please visit
More news about: TuHURA Biosciences, Inc.
May 12, 2026, 07:05 ET Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
baseline BMI ≥30 kg/m2 or BMI≥27 kg/m2 with at least one weight-related comorbid condition. 4) Least squares mean. 5) Two-sided t-test using mixed model for repeated measures. 6) Logistic regression model with treatment as factor and baseline weight as covariate.Poster
More news about: Viking Therapeutics, Inc.
May 12, 2026, 07:02 ET 1911 Gold Confirms Extensions of the L10 Zone at True North Intersecting 11.54 g/t Gold over 3.70 m
of 363,000 tonnes ("t") at 4.99 g/t Au for 67,000 ounces ("oz") and an inferred resource of 479,000 t at 3.96 g/t Au for 61,000 oz. 710-711 hosts a current indicated resource of 1,182,000 t at 5.21 g/t Au for 198,000 oz and an inferred resource of 938,000 t at 3.91 g/t Au for 118,000 oz.
More news about: 1911 Gold Corporation
May 12, 2026, 07:00 ET OceanaGold Announces Additional High-Grade Drill Results at Haile
15.5 m @ 30.64 g/t Au (UGD0121)30.5 m @ 13.86 g/t Au (UGD0113)22.5 m @ 13.42 g/t Au (UGD0122)18.4 m @ 9.62 g/t Au (UGD0119)21.9 m @ 6.48 g/t Au including 3.7 m @ 23.55 g/t Au (UGD0120)26.3 m @ 3.41 g/t Au and 44.3 m @
More news about: OceanaGold Corporation
May 12, 2026, 07:00 ET OceanaGold Announces Additional High-Grade Drill Results at Haile
15.5 m @ 30.64 g/t Au (UGD0121)30.5 m @ 13.86 g/t Au (UGD0113)22.5 m @ 13.42 g/t Au (UGD0122)18.4 m @ 9.62 g/t Au (UGD0119)21.9 m @ 6.48 g/t Au including 3.7 m @ 23.55 g/t Au (UGD0120)26.3 m @ 3.41 g/t Au and 44.3 m @
More news about: OceanaGold Corporation
May 12, 2026, 07:00 ET Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
inflammatory pathways linked to AD. Advanced analytics translate this biology into two results: a Janus kinase (JAK) Inhibitor Responder Profile or a T-helper 2 (Th2) Molecular Profile, providing clear, actionable guidance at the therapy-class level. AdvanceAD-Tx allows clinicians to match therapy to
More news about: Castle Biosciences, Inc.
May 12, 2026, 07:00 ET CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
that in normal human peripheral blood mononuclear cells (PBMCs) in a T-cell activation model, store-operated calcium entry (SOCE) blockers such as Auxora inhibit the expression of pro-inflammatory and cytotoxic genes within regulatory T cells, while crucially preserving tolerance-associated anti-inflammatory
More news about: CalciMedica, Inc.
May 12, 2026, 07:00 ET Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
Wyrtzen, Chief Marketing [email protected]T +44 (0)1865 582730Media EnquiriesUSAJordyn TemperatoLifeSci Communications
More news about: Brainomix
May 12, 2026, 07:00 ET LightInTheBox Reports First Quarter 2026 Financial Results
conference call by going to https://s1.c-conf.com/diamondpass/10054770-hu76t5.html. Upon registration, participants will receive dial-in numbers, an event passcode, and a unique access PIN.To join the
More news about: LightInTheBox Holding Co., Ltd.
May 12, 2026, 06:35 ET Knight presentará en la Conferencia Global de Salud 2026 de RBC Capital Markets en la ciudad de Nueva York
T: 514-484-4483 T. 598-2626-2344
More news about: Knight Therapeutics Inc.
May 12, 2026, 06:02 ET Brands that build trust through reviews increase AI citations from 1% to 75%, earn competitive advantage over 'invisible' brands
groups: T0 (Control) — No active Trustpilot profile (verified) - 437 brandsT1 — Minimal presence, low review volume - 497 brandsT2 — Active profile, moderate review volume - 497 brandsT3 — High review volume, actively managed
More news about: Trustpilot
May 12, 2026, 06:00 ET TCL CSOT Successfully Tops Out t8 Project Ahead of Schedule, Accelerating Mass Production of IJP OLED Technology
OLED line in China, known as t12, achieved mass production and product delivery in November 2024, providing mature experience and optimized yields necessary to drive the t8 project forward efficiently.As the world's first mass-production Gen 8.6 IJP OLED line, the t8 project utilizes inkjet-printing
More news about: TCL CSOT
May 12, 2026, 05:00 ET Tencent Music Entertainment Group Announces First Quarter 2026 Unaudited Financial Results
adoption and engagement. To enhance its appeal, we appointed major artists such as Ryan Ding, Ju Jingyi, Liu Yuning, JC-T, and Karry Wang as ambassadors for a variety of collaborations. We also introduced tailored
More news about: Tencent Music Entertainment Group
May 12, 2026, 04:55 ET ZTE Hosts 2026 Broadband User Congress in São Paulo, under the Theme "Monetize Your Intelligent Broadband"
enables fast, cost-effective network deployment, shortening time-to-market.Light OTN features a 12.8T-in-2U high-density design with minimalist WebGUI management, supporting single-wavelength 1.6T, zero-touch deployment and plug-and-play, reducing costs and O&M complexity while ensuring optimal
More news about: ZTE Corporation
May 12, 2026, 03:56 ET ZTE Hosts 2026 Broadband User Congress in São Paulo, under the Theme "Monetize Your Intelligent Broadband"
enables fast, cost-effective network deployment, shortening time-to-market.Light OTN features a 12.8T-in-2U high-density design with minimalist WebGUI management, supporting single-wavelength 1.6T, zero-touch deployment and plug-and-play, reducing costs and O&M complexity while ensuring optimal
More news about: ZTE Corporation
May 12, 2026, 03:09 ET 中興2026聖保羅寬帶用戶大會成功舉辦，以「智慧寬帶變現未來」共探智能寬帶商業新增長
變現未來」戰略構想轉化為可落地、可盈利的商業實踐。面向運營商寬帶網絡建設，中興通訊始終致力於為每一位客戶打造「最好的寬帶網絡」。在光接入領域， FTTx變現方案通過輕量化OLT降低建網門檻、CEM+AI實現精細化質差分析與精準營銷、AI全光園區與AI智會屏等創新拓展To B藍海市場，兼顧成本效率與ARPU提升，持續挖掘網絡增量價值。端到端智能ODN系統則為全生命週期網絡提供有力保障。在承載網領域， C+L全頻一體化1.6T OTN方案，融合AI技術，憑借單波速率升級、極致頻譜利用率與智能化運維能力，攻克光網擴容成本高、服務響應慢等行業難題。同時，單槽28.8Tbps核心路由器與高性能100GE/400GE接入匯聚路由器，疊加AI流量智能調優、AI安全防護、AI動態節能功能，助力運營商搭建超寬、綠色、安全、智能的新一代
More news about: 中興通訊股份有限公司
May 12, 2026, 03:07 ET Volvo Trucks' all-new combustion engine platform: Superior fuel efficiency and ready for a wide range of alternative fuels
produced in Skövde, Sweden and the trucks are assembled in Tuve, Sweden and Ghent, Belgium* Example based on simulations of a Volvo FH 42 T 500 hp 35-tonne GCW with the new D13 engine and use of Cruise Control, I-See and I-Roll with engine stop/start functionality, versus the previous standard
More news about: Volvo Trucks
May 12, 2026, 03:05 ET FALCON GOLD RECEIVES DRILL PERMIT FOR CENTRAL CANADA GOLD PROJECT, ATIKOKAN ONTARIO -QUETICO FAULT ZONE
targeting.Key results reported from these programs included:10.17 g/t Au over 3.0 metres starting at 67.0m and 18.6 g/t Au over 1.0m (with visible gold) from 104m in CC20-012.8 g/t Au over 7.5m from 158.1m in CC20-09Drilling and historical data have defined several
More news about: Falcon Gold Corp.
May 12, 2026, 03:04 ET ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
Zürich then shared clinical insights on CAR T-cell therapy. In her talk "Advancing CAR T-cell Therapy: Non-viral Engineering, Immune Evasion, and Modular Platform", she presented data from 36 B-ALL patients treated with Sleeping Beauty-engineered anti-CD19 CAR T cells, achieving an 83% complete remission
More news about: ACROBiosystems Group
May 12, 2026, 03:00 ET SkylineDx to Showcase New Cutaneous Squamous Cell Carcinoma Findings at 83rd Society for Investigative Dermatology Annual Meeting
addresses the need for improved metastatic risk stratification, as more than one-third of metastases occur in patients initially classified as "low risk" (T1, T2a), which represents 90% of patients. This SCCore GEP gene expression signature may enable more precise risk stratification by revealing biological risk
More news about: SkylineDx